Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract
This article argues that improving financial outcomes—including more reliable revenue recognition—requires revisiting the ...
In this video interview following the 2026 DIA Global Annual Meeting, Jonathan Andrus, co-CEO of CRIO, explains why ...
Orbis serves as the intelligence layer connecting ICON's clinical, operational, and enterprise data. The Microsoft ...
In today's ACT Brief, we examine regulatory uncertainty and 2026 breakthroughs shaping clinical research, reimagining CRO ...
In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...
Insilico Medicine and SK Biopharmaceuticals entered an R&D collaboration on AI-enabled drug discovery in neuroimmune CNS ...
In this video interview from the 2026 DIA Global Annual Meeting, Kevin Bugin, head of global regulatory policy and ...
In this video interview from the 2026 DIA Global Annual Meeting, Joan Chambers, independent senior consultant at Tufts CSDD, ...
In this video interview, Marwan Fathallah, president and CEO of DIA Global, shares the key trends and themes shaping this ...
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
In today's ACT Brief, we examine real-time evidence generation priorities, automating protocol digitization, and ...
Traditional CRO contracting models create misalignment between effort, progress, and financial outcomes, driving revenue recognition risk and margin volatility, but shared performance contracts ...
In today's ACT Brief, we examine building infrastructure for real-time clinical and real-world data integration, modernizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results